204 related articles for article (PubMed ID: 35150791)
1. Super enhancers as master gene regulators in the pathogenesis of hematologic malignancies.
Dębek S; Juszczyński P
Biochim Biophys Acta Rev Cancer; 2022 Mar; 1877(2):188697. PubMed ID: 35150791
[TBL] [Abstract][Full Text] [Related]
2. Super enhancer lncRNAs: a novel hallmark in cancer.
Song P; Han R; Yang F
Cell Commun Signal; 2024 Apr; 22(1):207. PubMed ID: 38566153
[TBL] [Abstract][Full Text] [Related]
3. Super-enhancer-driven TOX2 mediates oncogenesis in Natural Killer/T Cell Lymphoma.
Zhou J; Toh SH; Tan TK; Balan K; Lim JQ; Tan TZ; Xiong S; Jia Y; Ng SB; Peng Y; Jeyasekharan AD; Fan S; Lim ST; Ong CJ; Ong CK; Sanda T; Chng WJ
Mol Cancer; 2023 Apr; 22(1):69. PubMed ID: 37032358
[TBL] [Abstract][Full Text] [Related]
4. Super-enhancers in cancer.
Thandapani P
Pharmacol Ther; 2019 Jul; 199():129-138. PubMed ID: 30885876
[TBL] [Abstract][Full Text] [Related]
5. Super-enhancers: critical roles and therapeutic targets in hematologic malignancies.
Jia Y; Chng WJ; Zhou J
J Hematol Oncol; 2019 Jul; 12(1):77. PubMed ID: 31311566
[TBL] [Abstract][Full Text] [Related]
6. Super-enhancers and novel therapeutic targets in colorectal cancer.
Liu Q; Guo L; Lou Z; Xiang X; Shao J
Cell Death Dis; 2022 Mar; 13(3):228. PubMed ID: 35277481
[TBL] [Abstract][Full Text] [Related]
7. Oncogenic super-enhancer formation in tumorigenesis and its molecular mechanisms.
Jia Q; Chen S; Tan Y; Li Y; Tang F
Exp Mol Med; 2020 May; 52(5):713-723. PubMed ID: 32382065
[TBL] [Abstract][Full Text] [Related]
8. Super-Enhancers Dysregulations in Hematological Malignancies.
Belloucif Y; Lobry C
Cells; 2022 Jan; 11(2):. PubMed ID: 35053311
[TBL] [Abstract][Full Text] [Related]
9. Dissecting super-enhancer driven transcriptional dependencies reveals novel therapeutic strategies and targets for group 3 subtype medulloblastoma.
Li M; Han Y; Wang C; Kang W; Jiang W; Zhang L; Tang Y
J Exp Clin Cancer Res; 2022 Oct; 41(1):311. PubMed ID: 36273157
[TBL] [Abstract][Full Text] [Related]
10. [Research progress of super enhancer in cancer].
Wu ZQ; Mi ZY
Yi Chuan; 2019 Jan; 41(1):41-51. PubMed ID: 30686784
[TBL] [Abstract][Full Text] [Related]
11. Metabolic reprogramming directed by super-enhancers in tumors: An emerging landscape.
Zhou Z; Li J; Ousmane D; Peng L; Yuan X; Wang J
Mol Ther; 2024 Mar; 32(3):572-579. PubMed ID: 38327048
[TBL] [Abstract][Full Text] [Related]
12. Super-Enhancer-Driven Transcriptional Dependencies in Cancer.
Sengupta S; George RE
Trends Cancer; 2017 Apr; 3(4):269-281. PubMed ID: 28718439
[TBL] [Abstract][Full Text] [Related]
13. The molecular understanding of super-enhancer dysregulation in cancer.
Yoshino S; Suzuki HI
Nagoya J Med Sci; 2022 May; 84(2):216-229. PubMed ID: 35967935
[TBL] [Abstract][Full Text] [Related]
14. Super-enhancers complexes zoom in transcription in cancer.
Wang M; Chen Q; Wang S; Xie H; Liu J; Huang R; Xiang Y; Jiang Y; Tian D; Bian E
J Exp Clin Cancer Res; 2023 Jul; 42(1):183. PubMed ID: 37501079
[TBL] [Abstract][Full Text] [Related]
15. Etiology of super-enhancer reprogramming and activation in cancer.
Zhou RW; Parsons RE
Epigenetics Chromatin; 2023 Jul; 16(1):29. PubMed ID: 37415185
[TBL] [Abstract][Full Text] [Related]
16. The Emerging Role of Super-enhancers as Therapeutic Targets in The Digestive System Tumors.
Li XP; Qu J; Teng XQ; Zhuang HH; Dai YH; Yang Z; Qu Q
Int J Biol Sci; 2023; 19(4):1036-1048. PubMed ID: 36923930
[TBL] [Abstract][Full Text] [Related]
17. Super-Enhancers, Phase-Separated Condensates, and 3D Genome Organization in Cancer.
Tang SC; Vijayakumar U; Zhang Y; Fullwood MJ
Cancers (Basel); 2022 Jun; 14(12):. PubMed ID: 35740532
[TBL] [Abstract][Full Text] [Related]
18. Oncogenic super-enhancers in cancer: mechanisms and therapeutic targets.
Bacabac M; Xu W
Cancer Metastasis Rev; 2023 Jun; 42(2):471-480. PubMed ID: 37059907
[TBL] [Abstract][Full Text] [Related]
19. Experimental Validation and Prediction of Super-Enhancers: Advances and Challenges.
Kravchuk EV; Ashniev GA; Gladkova MG; Orlov AV; Vasileva AV; Boldyreva AV; Burenin AG; Skirda AM; Nikitin PI; Orlova NN
Cells; 2023 Apr; 12(8):. PubMed ID: 37190100
[TBL] [Abstract][Full Text] [Related]
20. Super-enhancers: A new frontier for glioma treatment.
Cheng M; Zhang ZW; Ji XH; Xu Y; Bian E; Zhao B
Biochim Biophys Acta Rev Cancer; 2020 Apr; 1873(2):188353. PubMed ID: 32112817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
